PlainRecalls
FDA Drug Moderate Class II Ongoing

Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10

Reported: March 27, 2024 Initiated: February 20, 2024 #D-0390-2024

Product Description

Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Details

Recalling Firm
Eugia US LLC
Units Affected
335,940 vials
Distribution
Nationwide within the United States
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10. Recalled by Eugia US LLC. Units affected: 335,940 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Which agency issued this recall?
This recall was issued by the FDA Drug on March 27, 2024. Severity: Moderate. Recall number: D-0390-2024.